Startseite Kongressberichte & Archiv Archiv 2014 ESMO 2014, Madrid 26 - 30 September 2014 Anti-EGFR or anti-VEGF in first-line RAS wild-type metastastic CRC patients Interview with Prof. Heinz-Josef Lenz, M.D., FACP, USC Norris Comprehensive Cancer Center, Los Angeles, USA

Comments on CALGB/SWOG 80405 & FIRE-3

Interview with Prof. Heinz-Josef Lenz, M.D., FACP, USC Norris Comprehensive Cancer Center, Los Angeles, USA: